【レポートの概要（一部）】
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models
Chapter 2: Executive Summary
2.1. Key Findings of The Study
2.2. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter’S Five Force Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. High Prevalence of Influenza
3.4.1.2. Increase In Government Focus On Immunization Programs
3.4.1.3. Emerging Vaccines
3.4.1.4. Technological Progress In Vaccine Administration
3.4.2. Restraints
3.4.2.1. Longer Timelines And Implementation of Stringent Regulations
3.4.2.2. High Costs Associated With The Development of Vaccines
3.4.3. Opportunity
3.4.3.1. High Growth Prospects In Emerging Markets
Chapter 4: Influenza Vaccine Market, By Vaccine Type
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Quadrivalent
4.2.1. Key Market Trends And Opportunities
4.2.2. Market Size And Forecast
4.2.3. Market Analysis, By Country
4.3. Trivalent
4.3.1. Key Market Trends And Opportunities
4.3.2. Market Size And Forecast
4.3.3. Market Analysis, By Country
Chapter 5: Influenza Vaccine Market, By Type
5.1. Overview
5.2. Seasonal Influenza Vaccine
5.3. Pandemic Influenza Vaccine
Chapter 6: Influenza Vaccine Market, By Technology
6.1. Overview
6.1.1. Market Size And Forecast
6.2. Egg-Based
6.2.1. Market Size And Forecast
6.2.2. Market Analysis, By Country
6.3. Cell Culture
6.3.1. Market Size And Forecast, By Region
6.3.2. Market Analysis, By Country
Chapter 7: Influenza Vaccine Market, By Age Group
7.1. Overview
7.1.1. Market Size And Forecast
7.2. Pediatric
7.2.1. Market Size And Forecast, By Region
7.2.2. Market Analysis, By Country
7.3. Adult
7.3.1. Market Size And Forecast, By Region
7.3.2. Market Analysis, By Country
Chapter 8: Influenza Vaccine Market, By Route of Administration
8.1. Overview
8.1.1. Market Size And Forecast
8.2. Injection
8.2.1. Market Size And Forecast
8.2.2. Market Analysis, By Country
8.3. Nasal Spray
8.3.1. Market Size And Forecast
8.3.2. Market Analysis, By Country
Chapter 9: Global Influenza Vaccine Market, By Region
9.1. Overview
9.1.1. Market Size And Forecast
9.2. North America
9.2.1. Key Market Trends And Opportunities
9.2.2. Market Size And Forecast, By Vaccine Type
9.2.3. Market Size And Forecast, By Technology
9.2.4. Market Size And Forecast, By Age Group
9.2.5. Market Size And Forecast, By Route of Administration
9.2.6. Market Size And Forecast, By Country
9.2.6.1. U.S. Market Size And Forecast, By Vaccine Type
9.2.6.2. U.S. Market Size And Forecast, By Technology
9.2.6.3. U.S. Market Size And Forecast, By Age Group
9.2.6.4. U.S. Market Size And Forecast, By Route of Administration
9.2.6.5. Canada Market Size And Forecast, By Vaccine Type
9.2.6.6. Canada Market Size And Forecast, By Technology
9.2.6.7. Canada Market Size And Forecast, By Age Group
9.2.6.8. Canada Market Size And Forecast, By Route of Administration
9.2.6.9. Mexico Market Size And Forecast, By Vaccine Type
9.2.6.10. Mexico Market Size And Forecast, By Technology
9.2.6.11. Mexico Market Size And Forecast, By Age Group
9.2.6.12. Mexico Market Size And Forecast, By Route of Administration
9.3. Europe
9.3.1. Key Market Trends And Opportunities
9.3.2. Market Size And Forecast, By Vaccine Type
9.3.3. Market Size And Forecast, By Technology
9.3.4. Market Size And Forecast, By Age Group
9.3.5. Market Size And Forecast, By Route of Administration
9.3.6. Market Size And Forecast, By Country
9.3.6.1. Germany Market Size And Forecast, By Vaccine Type
9.3.6.2. Germany Market Size And Forecast, By Technology
9.3.6.3. Germany Market Size And Forecast, By Age Group
9.3.6.4. Germany Market Size And Forecast, By Route of Administration
9.3.6.5. France Market Size And Forecast, By Vaccine Type
9.3.6.6. France Market Size And Forecast, By Technology
9.3.6.7. France Market Size And Forecast, By Age Group
9.3.6.8. France Market Size And Forecast, By Route of Administration
9.3.6.9. Uk Market Size And Forecast, By Vaccine Type
9.3.6.10. Uk Market Size And Forecast, By Technology
9.3.6.11. Uk Market Size And Forecast, By Age Group
9.3.6.12. Uk Market Size And Forecast, By Route of Administration
9.3.6.13. Italy Market Size And Forecast, By Vaccine Type
9.3.6.14. Italy Market Size And Forecast, By Technology
9.3.6.15. Italy Market Size And Forecast, By Age Group
9.3.6.16. Italy Market Size And Forecast, By Route of Administration
9.3.6.17. Spain Market Size And Forecast, By Vaccine Type
9.3.6.18. Spain Market Size And Forecast, By Technology
9.3.6.19. Spain Market Size And Forecast, By Age Group
9.3.6.20. Spain Market Size And Forecast, By Route of Administration
9.3.6.21. Rest of Europe Market Size And Forecast, By Vaccine Type
9.3.6.22. Rest of Europe Market Size And Forecast, By Technology
9.3.6.23. Rest of Europe Market Size And Forecast, By Age Group
9.3.6.24. Rest of Europe Market Size And Forecast, By Route of Administration
9.4. Asia-Pacific
9.4.1. Key Market Trends And Opportunities
9.4.2. Market Size And Forecast, By Vaccine Type
9.4.3. Market Size And Forecast, By Technology
9.4.4. Market Size And Forecast, By Age Group
9.4.5. Market Size And Forecast, By Route of Administration
9.4.6. Market Size And Forecast, By Country
9.4.6.1. Japan Market Size And Forecast, By Vaccine Type
9.4.6.2. Japan Market Size And Forecast, By Technology
9.4.6.3. Japan Market Size And Forecast, By Age Group
9.4.6.4. Japan Market Size And Forecast, By Route of Administration
9.4.6.5. China Market Size And Forecast, By Vaccine Type
9.4.6.6. China Market Size And Forecast, By Technology
9.4.6.7. China Market Size And Forecast, By Age Group
9.4.6.8. China Market Size And Forecast, By Route of Administration
9.4.6.9. India Market Size And Forecast, By Vaccine Type
9.4.6.10. India Market Size And Forecast, By Technology
9.4.6.11. India Market Size And Forecast, By Age Group
9.4.6.12. India Market Size And Forecast, By Route of Administration
9.4.6.13. Australia Market Size And Forecast, By Vaccine Type
9.4.6.14. Australia Market Size And Forecast, By Technology
9.4.6.15. Australia Market Size And Forecast, By Age Group
9.4.6.16. Australia Market Size And Forecast, By Route of Administration
9.4.6.17. South Korea Market Size And Forecast, By Vaccine Type
9.4.6.18. South Korea Market Size And Forecast, By Technology
9.4.6.19. South Korea Market Size And Forecast, By Age Group
9.4.6.20. South Korea Market Size And Forecast, By Route of Administration
9.4.6.21. Rest of Asia-Pacific Market Size And Forecast, By Vaccine Type
9.4.6.22. Rest of Asia-Pacific Market Size And Forecast, By Technology
9.4.6.23. Rest of Asia-Pacific Market Size And Forecast, By Age Group
9.4.6.24. Rest of Asia-Pacific Market Size And Forecast, By Route of Administration
9.5. Lamea
9.5.1. Key Market Trends And Opportunities
9.5.2. Market Size And Forecast, By Vaccine Type
9.5.3. Market Size And Forecast, By Technology
9.5.4. Market Size And Forecast, By Age Group
9.5.5. Market Size And Forecast, By Route of Administration
9.5.6. Market Size And Forecast, By Country
9.5.6.1. Brazil Market Size And Forecast, By Vaccine Type
9.5.6.2. Brazil Market Size And Forecast, By Technology
9.5.6.3. Brazil Market Size And Forecast, By Age Group
9.5.6.4. Brazil Market Size And Forecast, By Route of Administration
9.5.6.5. Saudi Market Size And Forecast, By Vaccine Type
9.5.6.6. Saudi Market Size And Forecast, By Technology
9.5.6.7. Saudi Market Size And Forecast, By Age Group
9.5.6.8. Saudi Market Size And Forecast, By Route of Administration
9.5.6.9. South Africa Market Size And Forecast, By Vaccine Type
9.5.6.10. South Africa Market Size And Forecast, By Technology
9.5.6.11. South Africa Market Size And Forecast, By Age Group
9.5.6.12. South Africa Market Size And Forecast, By Route of Administration
9.5.6.13. Rest of Lamea Market Size And Forecast, By Vaccine Type
9.5.6.14. Rest of Lamea Market Size And Forecast, By Technology
9.5.6.15. Rest of Lamea Market Size And Forecast, By Age Group
9.5.6.16. Rest of Lamea Market Size And Forecast, By Route of Administration
Chapter 10: Company Profiles
10.1. Astrazeneca Plc (Astrazeneca)
10.1.1. Company Overview
10.1.2. Company Snapshot
10.1.3. Operating Business Segments
10.1.4. Product Portfolio
10.1.5. Business Performance
10.2. Biodiem
10.2.1. Company Overview
10.2.2. Company Snapshot
10.2.3. Operating Business Segments
10.2.4. Product Portfolio
10.2.5. Business Performance
10.3. Csl Limited (Seqirus Gmbh)
10.3.1. Company Overview
10.3.2. Company Snapshot
10.3.3. Operating Business Segments
10.3.4. Product Portfolio
10.3.5. Business Performance
10.3.6. Key Strategic Moves And Developments
10.4. Emergent Biosolutions
10.4.1. Company Overview
10.4.2. Company Snapshot
10.4.3. Operating Business Segments
10.4.4. Product Portfolio
10.4.5. Business Performance
10.5. F. Hoffmann-La Roche Ltd.
10.5.1. Company Overview
10.5.2. Company Snapshot
10.5.3. Operating Business Segments
10.5.4. Product Portfolio
10.5.5. Business Performance
10.6. Gamma Vaccines Pty Ltd.
10.6.1. Company Overview
10.6.2. Company Snapshot
10.6.3. Operating Business Segments
10.6.4. Product Portfolio
10.7. Glaxosmithkline Plc
10.7.1. Company Overview
10.7.2. Company Snapshot
10.7.3. Operating Business Segments
10.7.4. Product Portfolio
10.7.5. Business Performance
10.7.6. Key Strategic Moves And Developments
10.8. Merck & Co., Inc. (Merck Sharp & Dohme Corp.)
10.8.1. Company Overview
10.8.2. Company Snapshot
10.8.3. Operating Business Segments
10.8.4. Product Portfolio
10.8.5. Business Performance
10.9. Novartis Ag
10.9.1. Company Overview
10.9.2. Company Snapshot
10.9.3. Operating Business Segments
10.9.4. Product Portfolio
10.9.5. Business Performance
10.10. Pfizer, Inc.
10.10.1. Company Overview
10.10.2. Company Snapshot
10.10.3. Operating Business Segments
10.10.4. Product Portfolio
10.10.5. Business Performance
10.10.6. Key Strategic Moves And Developments
10.11. Sanofi
10.11.1. Company Overview
10.11.2. Company Snapshot
10.11.3. Operating Business Segments
10.11.4. Product Portfolio
10.11.5. Business Performance
10.12. Sinovac Biotech Ltd.
10.12.1. Company Overview
10.12.2. Company Snapshot
10.12.3. Operating Business Segments
10.12.4. Product Portfolio
10.12.5. Business Performance
【レポート販売概要】
■ タイトル：インフルエンザワクチンの世界市場：ワクチンタイプ別（四価、三価）、タイプ別（季節性、パンデミック）、技術別（卵ベース、細胞ベース）、年齢別（小児、成人）、投与経路別（注射、点鼻薬）■ 英文：Influenza Vaccine Market by Vaccine Type (Quadrivalent and Trivalent), Type (Seasonal and Pandemic), Technology (Egg-based and Cell-based), Age Group (Pediatric and Adult), and Route of Administration (Injection and Nasal Spray): Global Opportunity Analysis and Industry Forecast, 2019-2026
■ 発行日：2019年10月
■ 調査会社：Allied Market Research
■ 商品コード：AMR9DC028
■ 調査対象地域：グローバル
- 産業用サイバーセキュリティの世界市場：サイバーセキュリティサービス/ソフトウェア/装置About Industrial Cyber Security Cyber threats are internet-based attempts that disrupt or damage IT systems and hack critical information using spyware, malware, and phishing. The major attacks seen in the utilities and manufacturing plants include phishing, watering hole, Stuxnet malware, DoS, and brute-force. Cyber security solutions help organizations detect, monitor, report, and counter cyber …
- 公共事業向けドローンの世界市場予測（～2023年）“The utility drones market is projected to grow at a CAGR of 37.34% from 2018 to 2023.” The utility drones market is projected to reach USD 538.6 million by 2023, from an estimated USD 110.2 million in 2018, at a CAGR of 37.34% from 2018 to 2023. This growth can be attributed to the rising demand for minimizing outages related to transmission and distribution infrastructure, focus on time and cost …
- 世界のマイクロディスプレイー市場動向（2014-2018）About Microdisplays Microdisplays are microminiaturized displays with a diagonal screen size of less than 25 mm. They are basically high-density, high resolution screens used in magnified display systems. They have two basic applications-- projection and near-to-eye display—and appear in devices across various sectors such as automotive, consumer electronics, healthcare, and industrial. Microdispl …
- 業務用照明器具の世界市場2016-2020About Luminaires Luminaires based on LED and conventional light sources include CFL, fluorescent lamps, halogen, HID, and incandescent. LED-based luminaires will account for the largest market share because of their energy efficiency and low operational costs. An LED light bulb on an average consumes 30%-50% less power than a conventional light bulb. In addition, LED bulbs are eco-friendly as they …
- Cosmo Oil Co., Ltd.：石油・ガスバリューチェーン分析レポート2013Cosmo Oil Co., Ltd. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Cosmo Oil Co., Ltd." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Cosmo Oil Co., Ltd.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examine …
- テクニカル・セラミックスの世界市場：一体型セラミックス、セラミックスマトリックス複合材料、セラミックコーティングAbout Technical Ceramics Technical ceramics are inorganic or non-metallic ceramics with high temperature stability, high hardness, and low thermal expansion. Further, these ceramics exhibit electrical properties ranging from insulators to semiconductors to highly conductive materials. These ceramics can be categorized into monolithic ceramics, ceramic matrix composites (CMCs), ceramic coatings, an …
- 世界の低温ポリシリコン市場2015The Global Low Temperature Poly-silicon (LTPS) Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Low Temperature Poly-silicon (LTPS) industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Low Temperature Poly-silicon (LTPS) market analysis is provided fo …
- 中東・アフリカ（MENA）の継目無銅管市場2015-2019About Seamless Copper Tubes The seamless copper tubes market in MENA is highly dependent on imports from suppliers in China, the Far East (Malaysia, Thailand, and Japan), the US, and Europe as there are no major local suppliers apart from Iran. Qaem Copper in Iran is a major supplier of seamless copper tubes in the region, mainly catering to the local demand in Iran and exporting in smaller quanti …
- Gastroenteritis：グローバル臨床試験レビューH2, 2013Gastroenteritis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Gastroenteritis Global Clinical Trials Review, H2, 2013" provides data on the Gastroenteritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gastroenteritis. It includes an overview of the trial numbers and their recruitment status as …
- 非小細胞肺癌：世界市場（医薬品市場予測及び分析～2022）PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of targeted therapies for patients with specific biomarkers has begun to fragment the NSCLC …
- マイクロ・ハイブリッド車の世界市場2015-2019The global 48V micro hybrid market is relatively new and still in its nascent stage. It is expected to grow exponentially in the coming years because of the benefits associated with the Class2 category of micro-hybrid vehicles. Technavio’s market research analysts project the global micro-hybrid vehicle market to grow at a CAGR of over 29% in the next four years. The conventional versions of micro …
- 耐熱塗料の世界市場：シリコーン樹脂、エポキシ樹脂、アクリル樹脂、ポリエステル樹脂、変性樹脂The global heat resistant coating market size is projected to reach USD 6.16 Billion by 2021, registering a CAGR of 5.11% between 2016 and 2021. Increasing investments in new infrastructure developments, new housing projects, and renovation of non-residential buildings along with increasing demand from the automotive & transportation industry in China, India, and Brazil are driving the heat resist …
- 軍用インフラ及び物流サービスの世界市場2016-2020About Military Infrastructure and Logistics Resources The role of military infrastructure and logistics resources involves planning, processing, and controlling the physical flows of essential goods and supplies from the point of origin to the military bases in a cost efficient approach. The concept of a structured logistics system was introduced in military service during World War II. Over the y …
- 携帯電話ベース認証の世界市場2016-2020About Global Phone-Based Authentication Market The global phone-based authentication market is expected to grow during the forecast period because of the increasing global penetration of mobile phones and smart devices. Companies are replacing traditional token-based authentication with phone-based authentication techniques, which is driving the growth of the market. Technavio’s analysts forecast …
- Hemostasis：グローバル臨床試験レビューH1, 2013Hemostasis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Hemostasis Global Clinical Trials Review, H1, 2013" provides data on the Hemostasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemostasis. It includes an overview of the trial numbers and their recruitment status as per the site of tri …
